Your browser doesn't support javascript.
loading
The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.
Parikh, Sameer A; Achenbach, Sara J; Call, Timothy G; Rabe, Kari G; Ding, Wei; Leis, Jose F; Kenderian, Saad S; Chanan-Khan, Asher A; Koehler, Amber B; Schwager, Susan M; Muchtar, Eli; Fonder, Amie L; McCullough, Kristen B; Nedved, Adrienne N; Smith, Matthew D; Slager, Susan L; Kay, Neil E; Finnes, Heidi D; Shanafelt, Tait D.
Afiliación
  • Parikh SA; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Achenbach SJ; Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN, USA.
  • Call TG; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Rabe KG; Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN, USA.
  • Ding W; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Leis JF; Department of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
  • Kenderian SS; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Chanan-Khan AA; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.
  • Koehler AB; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Schwager SM; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Muchtar E; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Fonder AL; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • McCullough KB; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Nedved AN; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Smith MD; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Slager SL; Division of Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN, USA.
  • Kay NE; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
  • Finnes HD; Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Shanafelt TD; Division of Hematology, Stanford University School of Medicine, Palo Alto, CA, USA.
Cancer Med ; 9(10): 3390-3399, 2020 05.
Article en En | MEDLINE | ID: mdl-32187452

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crónica de Células B / Inhibidores de Proteínas Quinasas / Deprescripciones Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piperidinas / Adenina / Leucemia Linfocítica Crónica de Células B / Inhibidores de Proteínas Quinasas / Deprescripciones Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Med Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos